Comment by Irene

Most (if not all) new medicines came out of basic research supported by the NIH. This research was tweaked and patented by companies who profit from selling the drugs. Is start-to-finish government drug pipeline a better solution? Perhaps, but current academic culture doesn't support it. It's not just about pouring more taxpayer money.